SCHEMBL7143512

SCHEMBL7143512

COc1cc(NC(=O)OC(C)(C)C)c(N)cc1-c1ccc(F)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 4/20 0.45
HDAC2 Q92769 7/20 0.44
HDAC1 Q13547 5/20 0.44
ABCB1 P08183 1/20 0.43
ABCC1 P33527 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.41
PIK3CD O00329 1/20 0.41
ABL1 P00519 1/20 0.41
EGFR P00533 1/20 0.41
KDR P35968 1/20 0.41
PIK3CA P42336 1/20 0.41
PIK3CG P48736 1/20 0.41
BACE1 P56817 1/20 0.41
PRKDC P78527 1/20 0.41
PI4KB Q9UBF8 1/20 0.41
KCNQ4 P56696 1/20 0.40
KCNQ5 Q9NR82 1/20 0.40
GRM2 Q14416 1/20 0.40
RELA Q04206 1/20 0.39
CYP17A1 P05093 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7145392 0.91 HDAC2 (0.44) AAK1HDAC2HDAC1KCNQ4KCNQ5
SCHEMBL7144345 0.87 BCL9 (0.41) AAK1HDAC2HDAC1KCNQ4KCNQ5
SCHEMBL3766409 0.87 HDAC2 (0.51) AAK1HDAC2HDAC1KCNQ4KCNQ5
SCHEMBL7138096 0.86 AAK1 (0.43) AAK1HDAC2HDAC1ABCB1ABCC1
SCHEMBL7141294 0.86 HDAC2 (0.41) AAK1HDAC2HDAC1KCNQ4KCNQ5
SCHEMBL7141564 0.86 HDAC2 (0.45) AAK1HDAC2HDAC1KCNQ4KCNQ5
SCHEMBL7142641 0.85 AAK1 (0.43) AAK1HDAC2HDAC1ABCB1ABCC1
SCHEMBL7145949 0.85 HDAC2 (0.40) AAK1HDAC2HDAC1KCNQ4KCNQ5
SCHEMBL7141577 0.85 HDAC2 (0.44) AAK1HDAC2HDAC1KCNQ4KCNQ5
SCHEMBL7142729 0.84 KCNQ4 (0.40) AAK1HDAC2HDAC1PIK3CDABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-B1 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2003-09-17 EP disclosed
EP-1224174-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
US-6407094-B1 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA HOFFMANN-LA ROCHE INC. 2002-06-18 US disclosed
WO-2001029011-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-26 WO disclosed